Hydroxychloroquine, one of the antimalarials currently being evaluated as a potential treatment for coronavirus, continues to be in the spotlight with India now taking steps to safeguard home market requirements.
On 25 March, the country’s ministry of commerce and industry prohibited the export of hydroxychloroquine and its formulations “with immediate...